Background: As a Class A bioterrorism agent, botulinum neurotoxin serotype A (BoNT/A) carries the risk of being used by terrorists to cause mass poisoning. The microneedle (MN) patch has a great potential for application as a novel vaccine delivery method. The aim of this study is to develop a thermally stable, dissolving microneedle patch for the delivery of a recombinant protein vaccine using a recombinant C-terminal heavy chain of BoNT/A (Hc of BoNT/A, AHc) to prevent botulism. Methods: Fish gelatin, a natural non-toxic and bacteriostatic material, was selected as the microneedle matrix for the preparation of the dissolving microneedle vaccine. Subsequently, the mechanical performance, bacteriostatic properties, vaccination effect, and s...
Abstract — Botulism is a potentially lethal disease caused by one of seven homologous neurotoxic pro...
The purpose of this study was to optimize the manufacturing of dissolving microneedles (dMNs) and to...
Skin is an attractive but also very challenging immunisation site for particulate subunit vaccines. ...
The purpose of this study was to create a thermally stable formulation of influenza vaccine that can...
Delivery of large molecular weight biological molecules to the epidermis and dermis is constrained b...
Influenza prophylaxis would benefit from a vaccination method enabling simplified logistics and impr...
Microneedle (MN) patches are promising for transcutaneous vaccination because they enable vaccine an...
Dissolving microneedles are a subgroup of microneedle types that completely dissolve within the skin...
Vaccination remains the most important approach to offering protection from infectious diseases. How...
The potential of bioneedles to deliver influenza vaccines was investigated. Four influenza vaccine f...
Vaccine delivery to the skin via microneedles confers several advantages over the traditional hypode...
The potential of bioneedles to deliver influenza vaccines was investigated. Four influenza vaccine f...
Thesis: Ph. D., Massachusetts Institute of Technology, Department of Chemical Engineering, 2017.Cata...
Botulinum toxin A (BT) is used therapeutically for the treatment of primary focal hyperhidrosis, a c...
Avian influenza H7N9 virus has first emerged in 2013 and since then has spread in China in five seas...
Abstract — Botulism is a potentially lethal disease caused by one of seven homologous neurotoxic pro...
The purpose of this study was to optimize the manufacturing of dissolving microneedles (dMNs) and to...
Skin is an attractive but also very challenging immunisation site for particulate subunit vaccines. ...
The purpose of this study was to create a thermally stable formulation of influenza vaccine that can...
Delivery of large molecular weight biological molecules to the epidermis and dermis is constrained b...
Influenza prophylaxis would benefit from a vaccination method enabling simplified logistics and impr...
Microneedle (MN) patches are promising for transcutaneous vaccination because they enable vaccine an...
Dissolving microneedles are a subgroup of microneedle types that completely dissolve within the skin...
Vaccination remains the most important approach to offering protection from infectious diseases. How...
The potential of bioneedles to deliver influenza vaccines was investigated. Four influenza vaccine f...
Vaccine delivery to the skin via microneedles confers several advantages over the traditional hypode...
The potential of bioneedles to deliver influenza vaccines was investigated. Four influenza vaccine f...
Thesis: Ph. D., Massachusetts Institute of Technology, Department of Chemical Engineering, 2017.Cata...
Botulinum toxin A (BT) is used therapeutically for the treatment of primary focal hyperhidrosis, a c...
Avian influenza H7N9 virus has first emerged in 2013 and since then has spread in China in five seas...
Abstract — Botulism is a potentially lethal disease caused by one of seven homologous neurotoxic pro...
The purpose of this study was to optimize the manufacturing of dissolving microneedles (dMNs) and to...
Skin is an attractive but also very challenging immunisation site for particulate subunit vaccines. ...